Skip to content
★ Sign in to follow
JG

John G. Aunins

Seres Therapeutics, Inc.
Total declarations
30
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (21 ops.)
€3.4M

Latest filing published 28 Jan 2020 for Seres Therapeutics, Inc..

Filing timeline

BuySale
John G. Aunins

Insider track record

Disclosed buys
0
Disclosed sells
21
Signal history

John G. Aunins: trading record in brief

John G. Aunins discloses dealings in Seres Therapeutics, Inc. to SEC (Form 4). Over a trading history stretching from 26 June 2015 to 26 January 2020, the count stands at 30 filings.

The open-market record consists of 21 sales worth €3.4M, with no purchase. The rest of the record consists of 8 option exercises.

The latest filing, published on 28 January 2020, reports an option exercise in Seres Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to John G. Aunins

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations28 total

25 of 28 declarations